Analystreport

Prevail Therapeutics Inc. (NASDAQ: PRVL) is now covered by analysts at Citigroup Inc. They set a "buy" rating on the stock.

Prevail Therapeutics Inc.  (PRVL) 
Last prevail therapeutics inc. earnings: 11/12 09:30 am Check Earnings Report